- Craneware posts pre-tax profits of USD$6.1m for the six months to the end of December - 15% up on last time.

The value of 'new sales' contracts signed in the period increased 15% compared to H1 2015 and revenue increased 7% to USD23.1m (H1 2015: USD21.6m).

Adjusted EBITDA increased 12% to USD7.1m and the proposed interim dividend is up 19% at 7.5p per share.

Chief executive Keith Neilson said: "Major changes in reimbursement and care delivery models have made understanding and reducing the cost of care, while providing quality patient outcomes, mission-critical for every healthcare provider in the US. With 50% of healthcare payments anticipated to have a value-based component by 2018, our offerings are expanding to meet the challenges of this value-driven healthcare market and pioneer the Value Cycle.

"We are confident that our position as a trusted financial performance partner will strengthen and provide us with the opportunity for accelerated long term growth. "The strong sales performance in the first half of the year, and our high levels of recurring revenues coupled with a record sales pipeline provide us with confidence for the second half of the year and beyond."

At 9:30am: [LON:CRW] Craneware PLC share price was +5p at 755p

Story provided by